Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Nightmares in PTSD
NCT04448808Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2020
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in post-traumatic stress disorder (PTSD), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2020; status: completed.
02
Drugs
dronabinol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04448808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448808.